Abbonarsi

Pre-operative atrial fibrillation and early right ventricular failure after left ventricular assist device implantation: a systematic review and meta-analysis - 09/07/21

Doi : 10.1016/j.ahj.2021.05.009 
Veraprapas Kittipibul, MD a, Vanessa Blumer, MD b, Gabriel A. Hernandez, MD c, Marat Fudim, MD, MHS b, Robert Flowers, MD a, Sandra Chaparro, MD d, Richa Agarwal, MD b,
a Department of Medicine, University of Miami/Jackson Memorial Hospital, Miami, Florida 
b Division of Cardiology, Duke University Medical Center, Durham, North Carolina 
c Division of Cardiology, University of Mississippi Medical Center, Jackson, Mississippi 
d Advanced Heart Failure Program, Baptist Health South Florida, Miami, Florida 

Reprint requests: Richa Agarwal MD, FACC, Duke University Medical Center 2301 Erwin Road DUMC Box 3126 Durham, NC 27710Duke University Medical Center2301 Erwin Road DUMC Box 3126DurhamNC27710

Highlights

Concomitant AF is prevalent amongst advanced HF patients undergoing LVAD implantation (38.8%)
Pre-operative AF is not associated with higher risks of early post-operative RVF or the need for RVAD support after LVAD implantation
The association of different AF phenotypes and management with risk of post-LVAD RVF needs further investigation

Il testo completo di questo articolo è disponibile in PDF.

Riassunto

Background

Right ventricular failure (RVF) remains a major cause of morbidity and mortality after left ventricular assist device (LVAD). Atrial fibrillation (AF) is known for its deleterious effects on cardiac function and hemodynamics. The association of pre-operative AF with the risk of early post-LVAD RVF has not been well described.

Method

A comprehensive literature search was performed through April, 9 2021. Cohort studies comparing the risk of post-operative RVF and/or need for right ventricular assist device (RVAD) after LVAD in patients with or without AF were included. Pooled odds ratio (OR) with 95% confidence intervals (CI) and I2 statistic were calculated using the random-effects model.

Results

Six studies were included in the analysis. Post-operative RVF was reported in 5 studies (1,841 patients) and RVAD use was reported in 4 studies (1,355 patients). There is a non-significant trend toward a higher risk of post-operative RVF in the AF group (pooled OR=1.25, 95%CI=0.99-1.58). No significant association between AF and RVAD use is noted (pooled OR=1.17, 95%CI=0.82-1.66).

Conclusions

Pre-operative AF is not significantly associated with higher risks of post-operative RVF and RVAD use after LVAD implantation, although the trend toward higher post-operative RVF is observed in patients with pre-operative AF. Additional research using a larger study population is warranted to better understand the association of pre-operative AF and the development of post-LVAD RVF.

Il testo completo di questo articolo è disponibile in PDF.

Graphic Abstract




Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Keywords : None, ABBREVIATIONS: AF, Atrial fibrillation, BTT, Bridge to transplant, CI, Cardiac index, CVP, Central venous pressure, DT, Destination therapy, HF, Heart failure, LV, Left ventricle, LVAD, Left ventricular assist device, PAP, Pulmonary artery pressure, RV, Right ventricle, RVAD, Right ventricular assist device, RVF, Right ventricular failure


Mappa


© 2021  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 239

P. 120-128 - Settembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure
  • Marat Fudim, Toi Spates, Jie-Lena Sun, Veraprapas Kittipibul, Jeffrey M. Testani, Randall C. Starling, W.H. Wilson Tang, Adrian F. Hernandez, G. Michael Felker, Christopher M. O'Connor, Robert J. Mentz
| Articolo seguente Articolo seguente
  • Simplifying the ISCHEMIA trial algorithm for clinical practice: Identifying left main coronary artery disease using coronary artery calcium scans
  • Joel E. Money, Joseph B. Muhlestein, Steve Mason, Tami L. Bair, Kirk U. Knowlton, Benjamin D. Horne, Jeffrey L. Anderson

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.